Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Bugarski-Kirola, D.
47  Ergebnisse:
Personensuche X
?
1

P.0775 Adherence to background antipsychotic and pimavanser..:

Bugarski-Kirola, D. ; Abbs, B. ; Odetalla, R....
European Neuropsychopharmacology.  53 (2021)  - p. S565-S566 , 2021
Link: https://doi.org/10.1016/..
 
?
2

P.0779 Relationship between pimavanserin exposure and QTc i..:

Darwish, M. ; Bugarski-Kirola, D. ; Passarell, J....
European Neuropsychopharmacology.  53 (2021)  - p. S568-S569 , 2021
Link: https://doi.org/10.1016/..
 
?
3

P.578 ENHANCE trial: adherence to current antipsychotic and..:

Abbs, B. ; Bugarski-Kirola, D. ; Liu, I.Y...
European Neuropsychopharmacology.  40 (2020)  - p. S329 , 2020
Link: https://doi.org/10.1016/..
 
?
4

P.577 ADVANCE: phase 2, randomised, double-blind, placebo-c..:

Bugarski-Kirola, D. ; Arango, C. ; Fava, M....
European Neuropsychopharmacology.  40 (2020)  - p. S328-S329 , 2020
Link: https://doi.org/10.1016/..
 
?
5

A phase II/III trial of bitopertin monotherapy compared wit..:

Bugarski-Kirola, D. ; Wang, A. ; Abi-Saab, D..
European Neuropsychopharmacology.  24 (2014)  7 - p. 1024-1036 , 2014
Link: https://doi.org/10.1016/..
 
?
6

Development of the readiness for work questionnaire in schi..:

Potkin, S. ; Bugarski-Kirola, D. ; Edgar, C....
Value in Health.  16 (2013)  3 - p. A32 , 2013
Link: https://doi.org/10.1016/..
 
?
7

PRM30 Evaluating Readiness for Work in Patients With Schizo..:

Potkin, S. ; Bugarski-Kirola, D. ; Edgar, C..
Value in Health.  15 (2012)  7 - p. A650 , 2012
Link: https://doi.org/10.1016/..
 
?
8

PMH56 Negative Symptoms Have Greater Impact on Functioning ..:

Rabinowitz, J. ; Garibaldi, G. ; Levine, S....
Value in Health.  14 (2011)  7 - p. A296-A297 , 2011
Link: https://doi.org/10.1016/..
 
?
9

Sulpiride Augmentation in refractory depression:

Stanković, Ž. ; Živković-Milovanović, D. ; Bugarski-Kirola, D..
European Neuropsychopharmacology.  6 (1996)  - p. 48-49 , 1996
Link: https://doi.org/10.1016/..
 
?
10

The efficacy of sertraline in the treatment of major depres..:

Bugarski-Kirola, D. ; Damjanović, A. ; Paunović, V.R..
European Neuropsychopharmacology.  6 (1996)  - p. 124 , 1996
Link: https://doi.org/10.1016/..
 
?
11

Dexamethasone suppression test in depression:

Živkovic-Milovanović, Dj. ; Bugarski-Kirola, D. ; Stanković, Z..
European Neuropsychopharmacology.  6 (1996)  - p. 128-129 , 1996
Link: https://doi.org/10.1016/..
 
?
12

Transient global amnesia-possible aetiopathogenetic mechani..:

Bugarski-Kirola, D. ; Prokopljevic, C. ; Kovacevic, M.
European Neuropsychopharmacology.  6 (1996)  - p. 187 , 1996
Link: https://doi.org/10.1016/..
 
?
13

P-29 Fluoxetine versus moclobemide in elderly depressed pat..:

Bugarski-Kirola, D. ; Zivkovic, Dj. ; Stankovic, Z..
European Neuropsychopharmacology.  6 (1996)  - p. S20 , 1996
Link: https://doi.org/10.1016/..
 
?
14

P-2-35 Efficacy of fluoxetine in comparison to maprotiline ..:

Bugarski-Kirola, D. ; Totic, S. ; Damjanovic, A..
European Neuropsychopharmacology.  5 (1995)  3 - p. 286 , 1995
Link: https://doi.org/10.1016/..
 
?
15

P-2-122 Analysis of the Hamilton depression rating scale fa..:

Stanković, . ; ivković-Milovanović, Dj. ; Bugarski-Kirola, D..
European Neuropsychopharmacology.  5 (1995)  3 - p. 315-316 , 1995
Link: https://doi.org/10.1016/..
 
1-15